The increased levels of Ang‐2 in the airspaces during severe influenza pneumonia and the improvement in clinically relevant outcomes after Ang‐2 antagonism indicate that the Ang‐1/Ang‐2 Tie‐2 signaling axis may be a promising therapeutic target in influenza and potentially other causes of viral pneumonia. This evidence concerns the gene TEK and viral pneumonia.